IP Library Granted Patent US 9,855,256
Granted Patent B2
US 9,855,256 · App. 15/145,453 · Granted Jan 2, 2018

Cyclooxygenase inhibitor and calcium channel antagonist compositions and methods for use in urological procedures

Inventors: Gregory A. Demopulos (Mercer Island, WA); Jeffrey M. Herz (Mill Creek, WA); Wayne R. Gombotz (Kenmore, WA); Hui-rong Shen (Bothell, WA)
Assignee: Omeros Corporation
A61K31/4422A61K9/0034A61K9/08A61K31/00A61K31/192A61K31/21A61K31/40A61K31/44A61K31/455A61L31/16A61L2300/402A61L2300/41A61L2300/432
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,855,256
App. No.
15/145,453
Granted
Jan 2, 2018
Kind
B2
Abstract

Compositions of a cyclooxygenase inhibitor and a calcium channel antagonist in a liquid carrier. The composition may be administered the urinary tract during urological diagnostic, interventional, surgical and other medical procedures. One disclosed composition comprises ketoprofen and nifedipine in a liquid irrigation carrier, and includes a solubilizing agent, stabilizing agents and a buffering agent.

Claims (4)

1. A stable composition for use in inhibiting pain/inflammation and spasm, comprising a combination of ketoprofen, nifedipine, propyl gallate and sodium metabisulfite in a liquid carrier, wherein the ketoprofen and nifedipine are included at a ketoprofen to nifedipine molar ratio of 3:1 plus or minus 20%.

2. The composition of claim 1 , wherein the liquid carrier comprises an aqueous solvent.

3. The composition of claim 2 , wherein the composition further comprises polyethylene glycol 400 as a cosolvent.

4. The composition of claim 1 , wherein the composition further comprises a citric acid buffer.

Assignments (5)
RELEASE OF SECURITY INTEREST Recorded Nov 25, 2025
From: WILMINGTON SAVINGS FUND SOCIETY, FSB
To: OMEROS CORPORATION
Reel/Frame 073705/0970 →
CORRECTIVE ASSIGNMENT TO CORRECT THE CORRECT THE BOX TITLED"THIS DOCUMENT SERVES AS AN OATH/DECLARATION (37 CFR 1.63)" WAS ERRONEOUSLY CHECKED AND THIS BOX SHOULD NOT HAVE BEEN CHECKED, PREVIOUSLY RECORDED AT REEL: 67607 FRAME: 108. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY INTEREST. Recorded Dec 11, 2024
From: OMEROS CORPORATION
To: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS COLLATERAL AGENT
Reel/Frame 069715/0719 →
SECURITY INTEREST Recorded Jun 3, 2024
From: OMEROS CORPORATION
To: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS COLLATERAL AGENT
Reel/Frame 067607/0108 →
RELEASE OF SECURITY INTEREST Recorded Nov 15, 2018
From: CRG SERVICING LLC
To: OMEROS CORPORATION
Reel/Frame 047573/0577 →
SECURITY INTEREST Recorded Nov 7, 2016
From: OMEROS CORPORATION
To: CRG SERVICING LLC, AS ADMINISTRATIVE AGENT
Reel/Frame 040575/0110 →
Continuity (4)
Continuation 14316008 · Jun 26, 2014
Continuation 11384235 · Mar 17, 2006
Provisional Application 60683488 · May 20, 2005
Related Publication 20160317515A1 · Nov 3, 2016